Growth Metrics

Achieve Life Sciences (ACHV) Other Working Capital Changes (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Other Working Capital Changes for 17 consecutive years, with -$68000.0 as the latest value for Q1 2026.

  • Quarterly Other Working Capital Changes rose 20.0% to -$68000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $413000.0 through Mar 2026, up 123.71% year-over-year, with the annual reading at $322203.0 for FY2025, 488086.36% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was -$68000.0 at Achieve Life Sciences, down from $1.3 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.3 million in Q4 2025, with the low at -$774000.0 in Q4 2024.
  • Average Other Working Capital Changes over 5 years is $10864.4, with a median of $33.0 recorded in 2023.
  • The widest YoY moves for Other Working Capital Changes: up 785760.98% in 2025, down 229829.73% in 2025.
  • Achieve Life Sciences' Other Working Capital Changes stood at -$325000.0 in 2022, then plummeted by 71.69% to -$558000.0 in 2023, then plummeted by 38.71% to -$774000.0 in 2024, then surged by 273.13% to $1.3 million in 2025, then tumbled by 105.07% to -$68000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Other Working Capital Changes are -$68000.0 (Q1 2026), $1.3 million (Q4 2025), and $322203.0 (Q3 2025).